SUMO protein (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "SUMO protein" in English language version.

refsWebsite

Global rank English rank

63nih.gov

4^th place

40doi.org

2^nd place

9worldcat.org

5^th place

5semanticscholar.org

11^th place

8^th place

2harvard.edu

18^th place

17^th place

1nature.com

234^th place

397^th place

1jci.org

low place

1researchgate.net

120^th place

125^th place

doi.org

Hay RT (April 2005). "SUMO: a history of modification". Molecular Cell. 18 (1): 1–12. doi:10.1016/j.molcel.2005.03.012. PMID 15808504.
Palacios AV, Acharya P, Peidl AS, Beck MR, Blanco E, Mishra A, et al. (March 2024). "SumoPred-PLM: human SUMOylation and SUMO2/3 sites Prediction using Pre-trained Protein Language Model". NAR Genomics and Bioinformatics. 6 (1): lqae011. doi:10.1093/nargab/lqae011. PMC 10849187. PMID 38327870.
Matunis MJ, Coutavas E, Blobel G (December 1996). "A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex". The Journal of Cell Biology. 135 (6 Pt 1): 1457–1470. doi:10.1083/jcb.135.6.1457. PMC 2133973. PMID 8978815.
Mahajan R, Delphin C, Guan T, Gerace L, Melchior F (January 1997). "A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2". Cell. 88 (1): 97–107. doi:10.1016/S0092-8674(00)81862-0. PMID 9019411. S2CID 17819277.
Cheng TS, Chang LK, Howng SL, Lu PJ, Lee CI, Hong YR (February 2006). "SUMO-1 modification of centrosomal protein hNinein promotes hNinein nuclear localization". Life Sciences. 78 (10): 1114–1120. doi:10.1016/j.lfs.2005.06.021. PMID 16154161.
Gill G (October 2005). "Something about SUMO inhibits transcription". Current Opinion in Genetics & Development. 15 (5): 536–541. doi:10.1016/j.gde.2005.07.004. PMID 16095902.
Wei W, Yang P, Pang J, Zhang S, Wang Y, Wang MH, et al. (October 2008). "A stress-dependent SUMO4 sumoylation of its substrate proteins". Biochemical and Biophysical Research Communications. 375 (3): 454–459. doi:10.1016/j.bbrc.2008.08.028. PMID 18708028.
Zhang XD, Goeres J, Zhang H, Yen TJ, Porter AC, Matunis MJ (March 2008). "SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis". Molecular Cell. 29 (6): 729–741. doi:10.1016/j.molcel.2008.01.013. PMC 2366111. PMID 18374647.
Azuma Y, Arnaoutov A, Dasso M (November 2003). "SUMO-2/3 regulates topoisomerase II in mitosis". The Journal of Cell Biology. 163 (3): 477–487. doi:10.1083/jcb.200304088. PMC 2173648. PMID 14597774.
Saitoh H, Hinchey J (March 2000). "Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3". The Journal of Biological Chemistry. 275 (9): 6252–6258. doi:10.1074/jbc.275.9.6252. PMID 10692421.
Matic I, van Hagen M, Schimmel J, Macek B, Ogg SC, Tatham MH, et al. (January 2008). "In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy". Molecular & Cellular Proteomics. 7 (1): 132–144. doi:10.1074/mcp.M700173-MCP200. PMC 3840926. PMID 17938407.
Matic I, Macek B, Hilger M, Walther TC, Mann M (September 2008). "Phosphorylation of SUMO-1 occurs in vivo and is conserved through evolution". Journal of Proteome Research. 7 (9): 4050–4057. doi:10.1021/pr800368m. PMID 18707152.
Jalal D, Chalissery J, Hassan AH (March 2017). "Genome maintenance in Saccharomyces cerevisiae: the role of SUMO and SUMO-targeted ubiquitin ligases". Nucleic Acids Research. 45 (5): 2242–2261. doi:10.1093/nar/gkw1369. PMC 5389695. PMID 28115630.
Geiss-Friedlander R, Melchior F (December 2007). "Concepts in sumoylation: a decade on". Nature Reviews. Molecular Cell Biology. 8 (12): 947–956. doi:10.1038/nrm2293. PMID 18000527. S2CID 30462190.
Teng S, Luo H, Wang L (July 2012). "Predicting protein sumoylation sites from sequence features". Amino Acids. 43 (1): 447–455. doi:10.1007/s00726-011-1100-2. PMID 21986959. S2CID 14360760.
Ren J, Gao X, Jin C, Zhu M, Wang X, Shaw A, et al. (2009). "Systematic study of protein SUMOylation: Development of a site-specific predictor of SUMOsp 2.0". Proteomics. 9 (12): 3409–3412. doi:10.1002/pmic.200800646. PMID 19504496. S2CID 4900031.
Beauclair G, Bridier-Nahmias A, Zagury JF, Saïb A, Zamborlini A (November 2015). "JASSA: a comprehensive tool for prediction of SUMOylation sites and SIMs". Bioinformatics. 31 (21): 3483–3491. doi:10.1093/bioinformatics/btv403. PMID 26142185.
Cheng CH, Lo YH, Liang SS, Ti SC, Lin FM, Yeh CH, et al. (August 2006). "SUMO modifications control assembly of synaptonemal complex and polycomplex in meiosis of Saccharomyces cerevisiae". Genes & Development. 20 (15): 2067–2081. doi:10.1101/gad.1430406. PMC 1536058. PMID 16847351.
Pichler A, Knipscheer P, Saitoh H, Sixma TK, Melchior F (October 2004). "The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type". Nature Structural & Molecular Biology. 11 (10): 984–991. doi:10.1038/nsmb834. PMID 15378033. S2CID 28085778.
Mukhopadhyay D, Dasso M (June 2007). "Modification in reverse: the SUMO proteases". Trends in Biochemical Sciences. 32 (6): 286–295. doi:10.1016/j.tibs.2007.05.002. PMID 17499995.
Gutierrez-Morton E, Haluska C, Collins L, Rizkallah R, Tomko RJ, Wang Y (July 2024). "The polySUMOylation axis promotes nucleolar release of Tof2 for mitotic exit". Cell Reports. 43 (7): 114492. doi:10.1016/j.celrep.2024.114492. PMC 11298248. PMID 39002125.
Talhaoui I, Bernal M, Mullen JR, Dorison H, Palancade B, Brill SJ, et al. (November 2018). "Slx5-Slx8 ubiquitin ligase targets active pools of the Yen1 nuclease to limit crossover formation". Nature Communications. 9 (1): 5016. Bibcode:2018NatCo...9.5016T. doi:10.1038/s41467-018-07364-x. PMC 6258734. PMID 30479332.
Chymkowitch P, Nguéa PA, Aanes H, Robertson J, Klungland A, Enserink JM (January 2017). "TORC1-dependent sumoylation of Rpc82 promotes RNA polymerase III assembly and activity". Proceedings of the National Academy of Sciences of the United States of America. 114 (5): 1039–1044. Bibcode:2017PNAS..114.1039C. doi:10.1073/pnas.1615093114. PMC 5293095. PMID 28096404.
Cheng X, Yang W, Lin W, Mei F (September 2023). Schulte G (ed.). "Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?". Pharmacological Reviews. 75 (5): 979–1006. doi:10.1124/pharmrev.122.000784. PMC 10441629. PMID 37137717.
Wimmer P, Schreiner S (September 2015). "Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways". Viruses. 7 (9): 4854–4872. doi:10.3390/v7092849. ISSN 1999-4915. PMC 4584293. PMID 26343706.
Lee MH, Lee SW, Lee EJ, Choi SJ, Chung SS, Lee JI, et al. (December 2006). "SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination". Nature Cell Biology. 8 (12): 1424–1431. doi:10.1038/ncb1512. PMID 17086174.
Nishida T, Yamada Y (March 2011). "The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation". Biochemical and Biophysical Research Communications. 406 (2): 285–291. doi:10.1016/j.bbrc.2011.02.034. PMID 21316347.
Wu SY, Chiang CM (October 2009). "p53 sumoylation: mechanistic insights from reconstitution studies". Epigenetics. 4 (7): 445–451. doi:10.4161/epi.4.7.10030. PMC 4749140. PMID 19838051.
Seeler JS, Dejean A (March 2017). "SUMO and the robustness of cancer". Nature Reviews Cancer. 17 (3): 184–197. doi:10.1038/nrc.2016.143. ISSN 1474-1768. PMID 28134258.
Chang SC, Ding JL (2018-12-01). "Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870 (2): 165–175. doi:10.1016/j.bbcan.2018.08.002. ISSN 0304-419X. PMID 30318471.
Tam SY, Wu VW, Law HK (2020-04-08). "Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond". Frontiers in Oncology. 10: 486. doi:10.3389/fonc.2020.00486. ISSN 2234-943X. PMC 7156534. PMID 32322559.
Heo KS, Le NT, Cushman HJ, Giancursio CJ, Chang E, Woo CH, et al. (2015-03-02). "Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function". The Journal of Clinical Investigation. 125 (3): 1299–1310. doi:10.1172/JCI76453. ISSN 0021-9738. PMC 4362265. PMID 25689261.
Janaszak-Jasiecka A, Płoska A, Wierońska JM, Dobrucki LW, Kalinowski L (2023-03-09). "Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets". Cellular & Molecular Biology Letters. 28 (1): 21. doi:10.1186/s11658-023-00423-2. ISSN 1689-1392. PMC 9996905. PMID 36890458.
Zhang CP, Ding XX, Tian T, Li BJ, Wang CY, Jiang SS, et al. (2020-10-01). "Impaired lipophagy in endothelial cells with prolonged exposure to oxidized low‑density lipoprotein". Molecular Medicine Reports. 22 (4): 2665–2672. doi:10.3892/mmr.2020.11345. ISSN 1791-2997. PMC 7453646. PMID 32945384.
Wang X, Cao K, Sun X, Chen Y, Duan Z, Sun L, et al. (2015). "Macrophages in spinal cord injury: Phenotypic and functional change from exposure to myelin debris". Glia. 63 (4): 635–651. doi:10.1002/glia.22774. ISSN 1098-1136. PMC 4331228. PMID 25452166.
Du C, Chen X, Su Q, Lu W, Wang Q, Yuan H, et al. (January 2021). "The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications". International Journal of Molecular Sciences. 22 (19): 10618. doi:10.3390/ijms221910618. ISSN 1422-0067. PMC 8509021. PMID 34638970.
Folger A, Chen C, Kabbaj MH, Frey K, Wang Y (2023-12-31). "Neurodegenerative disease-associated inclusion bodies are cleared by selective autophagy in budding yeast". Autophagy Reports. 2 (1). doi:10.1080/27694127.2023.2236407. PMC 10482306. PMID 37680383.
Andrews EA, Palecek J, Sergeant J, Taylor E, Lehmann AR, Watts FZ (January 2005). "Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage". Molecular and Cellular Biology. 25 (1): 185–196. doi:10.1128/MCB.25.1.185-196.2005. PMC 538766. PMID 15601841.
Jacome A, Gutierrez-Martinez P, Schiavoni F, Tenaglia E, Martinez P, Rodríguez-Acebes S, et al. (November 2015). "NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity". The EMBO Journal. 34 (21): 2604–2619. doi:10.15252/embj.201591829. PMC 4641528. PMID 26443207.
Burgess R, Deutscher M (2009). "Chapter 17 Refolding Solubilized Inclusion Body Proteins". Guide to Protein Purification, 2nd Edition. Methods in Enzymology. Vol. 463 (2nd ed.). pp. 259–282. doi:10.1016/S0076-6879(09)63017-2. ISBN 978-0-12-374536-1. PMID 19892177.

harvard.edu

ui.adsabs.harvard.edu

Talhaoui I, Bernal M, Mullen JR, Dorison H, Palancade B, Brill SJ, et al. (November 2018). "Slx5-Slx8 ubiquitin ligase targets active pools of the Yen1 nuclease to limit crossover formation". Nature Communications. 9 (1): 5016. Bibcode:2018NatCo...9.5016T. doi:10.1038/s41467-018-07364-x. PMC 6258734. PMID 30479332.
Chymkowitch P, Nguéa PA, Aanes H, Robertson J, Klungland A, Enserink JM (January 2017). "TORC1-dependent sumoylation of Rpc82 promotes RNA polymerase III assembly and activity". Proceedings of the National Academy of Sciences of the United States of America. 114 (5): 1039–1044. Bibcode:2017PNAS..114.1039C. doi:10.1073/pnas.1615093114. PMC 5293095. PMID 28096404.

jci.org

Heo KS, Le NT, Cushman HJ, Giancursio CJ, Chang E, Woo CH, et al. (2015-03-02). "Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function". The Journal of Clinical Investigation. 125 (3): 1299–1310. doi:10.1172/JCI76453. ISSN 0021-9738. PMC 4362265. PMID 25689261.

nature.com

Seeler JS, Dejean A (March 2017). "SUMO and the robustness of cancer". Nature Reviews Cancer. 17 (3): 184–197. doi:10.1038/nrc.2016.143. ISSN 1474-1768. PMID 28134258.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hay RT (April 2005). "SUMO: a history of modification". Molecular Cell. 18 (1): 1–12. doi:10.1016/j.molcel.2005.03.012. PMID 15808504.
Palacios AV, Acharya P, Peidl AS, Beck MR, Blanco E, Mishra A, et al. (March 2024). "SumoPred-PLM: human SUMOylation and SUMO2/3 sites Prediction using Pre-trained Protein Language Model". NAR Genomics and Bioinformatics. 6 (1): lqae011. doi:10.1093/nargab/lqae011. PMC 10849187. PMID 38327870.
Matunis MJ, Coutavas E, Blobel G (December 1996). "A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex". The Journal of Cell Biology. 135 (6 Pt 1): 1457–1470. doi:10.1083/jcb.135.6.1457. PMC 2133973. PMID 8978815.
Mahajan R, Delphin C, Guan T, Gerace L, Melchior F (January 1997). "A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2". Cell. 88 (1): 97–107. doi:10.1016/S0092-8674(00)81862-0. PMID 9019411. S2CID 17819277.
Cheng TS, Chang LK, Howng SL, Lu PJ, Lee CI, Hong YR (February 2006). "SUMO-1 modification of centrosomal protein hNinein promotes hNinein nuclear localization". Life Sciences. 78 (10): 1114–1120. doi:10.1016/j.lfs.2005.06.021. PMID 16154161.
Gill G (October 2005). "Something about SUMO inhibits transcription". Current Opinion in Genetics & Development. 15 (5): 536–541. doi:10.1016/j.gde.2005.07.004. PMID 16095902.
Wei W, Yang P, Pang J, Zhang S, Wang Y, Wang MH, et al. (October 2008). "A stress-dependent SUMO4 sumoylation of its substrate proteins". Biochemical and Biophysical Research Communications. 375 (3): 454–459. doi:10.1016/j.bbrc.2008.08.028. PMID 18708028.
Zhang XD, Goeres J, Zhang H, Yen TJ, Porter AC, Matunis MJ (March 2008). "SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis". Molecular Cell. 29 (6): 729–741. doi:10.1016/j.molcel.2008.01.013. PMC 2366111. PMID 18374647.
Azuma Y, Arnaoutov A, Dasso M (November 2003). "SUMO-2/3 regulates topoisomerase II in mitosis". The Journal of Cell Biology. 163 (3): 477–487. doi:10.1083/jcb.200304088. PMC 2173648. PMID 14597774.
Saitoh H, Hinchey J (March 2000). "Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3". The Journal of Biological Chemistry. 275 (9): 6252–6258. doi:10.1074/jbc.275.9.6252. PMID 10692421.
Matic I, van Hagen M, Schimmel J, Macek B, Ogg SC, Tatham MH, et al. (January 2008). "In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy". Molecular & Cellular Proteomics. 7 (1): 132–144. doi:10.1074/mcp.M700173-MCP200. PMC 3840926. PMID 17938407.
Matic I, Macek B, Hilger M, Walther TC, Mann M (September 2008). "Phosphorylation of SUMO-1 occurs in vivo and is conserved through evolution". Journal of Proteome Research. 7 (9): 4050–4057. doi:10.1021/pr800368m. PMID 18707152.
Jalal D, Chalissery J, Hassan AH (March 2017). "Genome maintenance in Saccharomyces cerevisiae: the role of SUMO and SUMO-targeted ubiquitin ligases". Nucleic Acids Research. 45 (5): 2242–2261. doi:10.1093/nar/gkw1369. PMC 5389695. PMID 28115630.
Geiss-Friedlander R, Melchior F (December 2007). "Concepts in sumoylation: a decade on". Nature Reviews. Molecular Cell Biology. 8 (12): 947–956. doi:10.1038/nrm2293. PMID 18000527. S2CID 30462190.
Teng S, Luo H, Wang L (July 2012). "Predicting protein sumoylation sites from sequence features". Amino Acids. 43 (1): 447–455. doi:10.1007/s00726-011-1100-2. PMID 21986959. S2CID 14360760.
Ren J, Gao X, Jin C, Zhu M, Wang X, Shaw A, et al. (2009). "Systematic study of protein SUMOylation: Development of a site-specific predictor of SUMOsp 2.0". Proteomics. 9 (12): 3409–3412. doi:10.1002/pmic.200800646. PMID 19504496. S2CID 4900031.
Beauclair G, Bridier-Nahmias A, Zagury JF, Saïb A, Zamborlini A (November 2015). "JASSA: a comprehensive tool for prediction of SUMOylation sites and SIMs". Bioinformatics. 31 (21): 3483–3491. doi:10.1093/bioinformatics/btv403. PMID 26142185.
Cheng CH, Lo YH, Liang SS, Ti SC, Lin FM, Yeh CH, et al. (August 2006). "SUMO modifications control assembly of synaptonemal complex and polycomplex in meiosis of Saccharomyces cerevisiae". Genes & Development. 20 (15): 2067–2081. doi:10.1101/gad.1430406. PMC 1536058. PMID 16847351.
Pichler A, Knipscheer P, Saitoh H, Sixma TK, Melchior F (October 2004). "The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type". Nature Structural & Molecular Biology. 11 (10): 984–991. doi:10.1038/nsmb834. PMID 15378033. S2CID 28085778.
Mukhopadhyay D, Dasso M (June 2007). "Modification in reverse: the SUMO proteases". Trends in Biochemical Sciences. 32 (6): 286–295. doi:10.1016/j.tibs.2007.05.002. PMID 17499995.
Gutierrez-Morton E, Haluska C, Collins L, Rizkallah R, Tomko RJ, Wang Y (July 2024). "The polySUMOylation axis promotes nucleolar release of Tof2 for mitotic exit". Cell Reports. 43 (7): 114492. doi:10.1016/j.celrep.2024.114492. PMC 11298248. PMID 39002125.
Talhaoui I, Bernal M, Mullen JR, Dorison H, Palancade B, Brill SJ, et al. (November 2018). "Slx5-Slx8 ubiquitin ligase targets active pools of the Yen1 nuclease to limit crossover formation". Nature Communications. 9 (1): 5016. Bibcode:2018NatCo...9.5016T. doi:10.1038/s41467-018-07364-x. PMC 6258734. PMID 30479332.
Chymkowitch P, Nguéa PA, Aanes H, Robertson J, Klungland A, Enserink JM (January 2017). "TORC1-dependent sumoylation of Rpc82 promotes RNA polymerase III assembly and activity". Proceedings of the National Academy of Sciences of the United States of America. 114 (5): 1039–1044. Bibcode:2017PNAS..114.1039C. doi:10.1073/pnas.1615093114. PMC 5293095. PMID 28096404.
Cheng X, Yang W, Lin W, Mei F (September 2023). Schulte G (ed.). "Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?". Pharmacological Reviews. 75 (5): 979–1006. doi:10.1124/pharmrev.122.000784. PMC 10441629. PMID 37137717.
Wimmer P, Schreiner S (September 2015). "Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways". Viruses. 7 (9): 4854–4872. doi:10.3390/v7092849. ISSN 1999-4915. PMC 4584293. PMID 26343706.
Lee MH, Lee SW, Lee EJ, Choi SJ, Chung SS, Lee JI, et al. (December 2006). "SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination". Nature Cell Biology. 8 (12): 1424–1431. doi:10.1038/ncb1512. PMID 17086174.
Nishida T, Yamada Y (March 2011). "The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation". Biochemical and Biophysical Research Communications. 406 (2): 285–291. doi:10.1016/j.bbrc.2011.02.034. PMID 21316347.
Wu SY, Chiang CM (October 2009). "p53 sumoylation: mechanistic insights from reconstitution studies". Epigenetics. 4 (7): 445–451. doi:10.4161/epi.4.7.10030. PMC 4749140. PMID 19838051.
Seeler JS, Dejean A (March 2017). "SUMO and the robustness of cancer". Nature Reviews Cancer. 17 (3): 184–197. doi:10.1038/nrc.2016.143. ISSN 1474-1768. PMID 28134258.
Chang SC, Ding JL (2018-12-01). "Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870 (2): 165–175. doi:10.1016/j.bbcan.2018.08.002. ISSN 0304-419X. PMID 30318471.
Tam SY, Wu VW, Law HK (2020-04-08). "Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond". Frontiers in Oncology. 10: 486. doi:10.3389/fonc.2020.00486. ISSN 2234-943X. PMC 7156534. PMID 32322559.
Heo KS, Le NT, Cushman HJ, Giancursio CJ, Chang E, Woo CH, et al. (2015-03-02). "Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function". The Journal of Clinical Investigation. 125 (3): 1299–1310. doi:10.1172/JCI76453. ISSN 0021-9738. PMC 4362265. PMID 25689261.
Janaszak-Jasiecka A, Płoska A, Wierońska JM, Dobrucki LW, Kalinowski L (2023-03-09). "Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets". Cellular & Molecular Biology Letters. 28 (1): 21. doi:10.1186/s11658-023-00423-2. ISSN 1689-1392. PMC 9996905. PMID 36890458.
Zhang CP, Ding XX, Tian T, Li BJ, Wang CY, Jiang SS, et al. (2020-10-01). "Impaired lipophagy in endothelial cells with prolonged exposure to oxidized low‑density lipoprotein". Molecular Medicine Reports. 22 (4): 2665–2672. doi:10.3892/mmr.2020.11345. ISSN 1791-2997. PMC 7453646. PMID 32945384.
Wang X, Cao K, Sun X, Chen Y, Duan Z, Sun L, et al. (2015). "Macrophages in spinal cord injury: Phenotypic and functional change from exposure to myelin debris". Glia. 63 (4): 635–651. doi:10.1002/glia.22774. ISSN 1098-1136. PMC 4331228. PMID 25452166.
Du C, Chen X, Su Q, Lu W, Wang Q, Yuan H, et al. (January 2021). "The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications". International Journal of Molecular Sciences. 22 (19): 10618. doi:10.3390/ijms221910618. ISSN 1422-0067. PMC 8509021. PMID 34638970.
Folger A, Chen C, Kabbaj MH, Frey K, Wang Y (2023-12-31). "Neurodegenerative disease-associated inclusion bodies are cleared by selective autophagy in budding yeast". Autophagy Reports. 2 (1). doi:10.1080/27694127.2023.2236407. PMC 10482306. PMID 37680383.
Andrews EA, Palecek J, Sergeant J, Taylor E, Lehmann AR, Watts FZ (January 2005). "Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage". Molecular and Cellular Biology. 25 (1): 185–196. doi:10.1128/MCB.25.1.185-196.2005. PMC 538766. PMID 15601841.
Jacome A, Gutierrez-Martinez P, Schiavoni F, Tenaglia E, Martinez P, Rodríguez-Acebes S, et al. (November 2015). "NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity". The EMBO Journal. 34 (21): 2604–2619. doi:10.15252/embj.201591829. PMC 4641528. PMID 26443207.
Burgess R, Deutscher M (2009). "Chapter 17 Refolding Solubilized Inclusion Body Proteins". Guide to Protein Purification, 2nd Edition. Methods in Enzymology. Vol. 463 (2nd ed.). pp. 259–282. doi:10.1016/S0076-6879(09)63017-2. ISBN 978-0-12-374536-1. PMID 19892177.

ncbi.nlm.nih.gov

Palacios AV, Acharya P, Peidl AS, Beck MR, Blanco E, Mishra A, et al. (March 2024). "SumoPred-PLM: human SUMOylation and SUMO2/3 sites Prediction using Pre-trained Protein Language Model". NAR Genomics and Bioinformatics. 6 (1): lqae011. doi:10.1093/nargab/lqae011. PMC 10849187. PMID 38327870.
Matunis MJ, Coutavas E, Blobel G (December 1996). "A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex". The Journal of Cell Biology. 135 (6 Pt 1): 1457–1470. doi:10.1083/jcb.135.6.1457. PMC 2133973. PMID 8978815.
SUMO1 SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)
Zhang XD, Goeres J, Zhang H, Yen TJ, Porter AC, Matunis MJ (March 2008). "SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis". Molecular Cell. 29 (6): 729–741. doi:10.1016/j.molcel.2008.01.013. PMC 2366111. PMID 18374647.
Azuma Y, Arnaoutov A, Dasso M (November 2003). "SUMO-2/3 regulates topoisomerase II in mitosis". The Journal of Cell Biology. 163 (3): 477–487. doi:10.1083/jcb.200304088. PMC 2173648. PMID 14597774.
Matic I, van Hagen M, Schimmel J, Macek B, Ogg SC, Tatham MH, et al. (January 2008). "In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy". Molecular & Cellular Proteomics. 7 (1): 132–144. doi:10.1074/mcp.M700173-MCP200. PMC 3840926. PMID 17938407.
Jalal D, Chalissery J, Hassan AH (March 2017). "Genome maintenance in Saccharomyces cerevisiae: the role of SUMO and SUMO-targeted ubiquitin ligases". Nucleic Acids Research. 45 (5): 2242–2261. doi:10.1093/nar/gkw1369. PMC 5389695. PMID 28115630.
Cheng CH, Lo YH, Liang SS, Ti SC, Lin FM, Yeh CH, et al. (August 2006). "SUMO modifications control assembly of synaptonemal complex and polycomplex in meiosis of Saccharomyces cerevisiae". Genes & Development. 20 (15): 2067–2081. doi:10.1101/gad.1430406. PMC 1536058. PMID 16847351.
Gutierrez-Morton E, Haluska C, Collins L, Rizkallah R, Tomko RJ, Wang Y (July 2024). "The polySUMOylation axis promotes nucleolar release of Tof2 for mitotic exit". Cell Reports. 43 (7): 114492. doi:10.1016/j.celrep.2024.114492. PMC 11298248. PMID 39002125.
Talhaoui I, Bernal M, Mullen JR, Dorison H, Palancade B, Brill SJ, et al. (November 2018). "Slx5-Slx8 ubiquitin ligase targets active pools of the Yen1 nuclease to limit crossover formation". Nature Communications. 9 (1): 5016. Bibcode:2018NatCo...9.5016T. doi:10.1038/s41467-018-07364-x. PMC 6258734. PMID 30479332.
Chymkowitch P, Nguéa PA, Aanes H, Robertson J, Klungland A, Enserink JM (January 2017). "TORC1-dependent sumoylation of Rpc82 promotes RNA polymerase III assembly and activity". Proceedings of the National Academy of Sciences of the United States of America. 114 (5): 1039–1044. Bibcode:2017PNAS..114.1039C. doi:10.1073/pnas.1615093114. PMC 5293095. PMID 28096404.
Cheng X, Yang W, Lin W, Mei F (September 2023). Schulte G (ed.). "Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?". Pharmacological Reviews. 75 (5): 979–1006. doi:10.1124/pharmrev.122.000784. PMC 10441629. PMID 37137717.
Wimmer P, Schreiner S (September 2015). "Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways". Viruses. 7 (9): 4854–4872. doi:10.3390/v7092849. ISSN 1999-4915. PMC 4584293. PMID 26343706.
Wu SY, Chiang CM (October 2009). "p53 sumoylation: mechanistic insights from reconstitution studies". Epigenetics. 4 (7): 445–451. doi:10.4161/epi.4.7.10030. PMC 4749140. PMID 19838051.
Tam SY, Wu VW, Law HK (2020-04-08). "Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond". Frontiers in Oncology. 10: 486. doi:10.3389/fonc.2020.00486. ISSN 2234-943X. PMC 7156534. PMID 32322559.
Heo KS, Le NT, Cushman HJ, Giancursio CJ, Chang E, Woo CH, et al. (2015-03-02). "Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function". The Journal of Clinical Investigation. 125 (3): 1299–1310. doi:10.1172/JCI76453. ISSN 0021-9738. PMC 4362265. PMID 25689261.
Janaszak-Jasiecka A, Płoska A, Wierońska JM, Dobrucki LW, Kalinowski L (2023-03-09). "Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets". Cellular & Molecular Biology Letters. 28 (1): 21. doi:10.1186/s11658-023-00423-2. ISSN 1689-1392. PMC 9996905. PMID 36890458.
Zhang CP, Ding XX, Tian T, Li BJ, Wang CY, Jiang SS, et al. (2020-10-01). "Impaired lipophagy in endothelial cells with prolonged exposure to oxidized low‑density lipoprotein". Molecular Medicine Reports. 22 (4): 2665–2672. doi:10.3892/mmr.2020.11345. ISSN 1791-2997. PMC 7453646. PMID 32945384.
Wang X, Cao K, Sun X, Chen Y, Duan Z, Sun L, et al. (2015). "Macrophages in spinal cord injury: Phenotypic and functional change from exposure to myelin debris". Glia. 63 (4): 635–651. doi:10.1002/glia.22774. ISSN 1098-1136. PMC 4331228. PMID 25452166.
Du C, Chen X, Su Q, Lu W, Wang Q, Yuan H, et al. (January 2021). "The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications". International Journal of Molecular Sciences. 22 (19): 10618. doi:10.3390/ijms221910618. ISSN 1422-0067. PMC 8509021. PMID 34638970.
Folger A, Chen C, Kabbaj MH, Frey K, Wang Y (2023-12-31). "Neurodegenerative disease-associated inclusion bodies are cleared by selective autophagy in budding yeast". Autophagy Reports. 2 (1). doi:10.1080/27694127.2023.2236407. PMC 10482306. PMID 37680383.
Andrews EA, Palecek J, Sergeant J, Taylor E, Lehmann AR, Watts FZ (January 2005). "Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage". Molecular and Cellular Biology. 25 (1): 185–196. doi:10.1128/MCB.25.1.185-196.2005. PMC 538766. PMID 15601841.
Jacome A, Gutierrez-Martinez P, Schiavoni F, Tenaglia E, Martinez P, Rodríguez-Acebes S, et al. (November 2015). "NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity". The EMBO Journal. 34 (21): 2604–2619. doi:10.15252/embj.201591829. PMC 4641528. PMID 26443207.

researchgate.net

Kuo D, Nie M, Courey A (2014). Protein Affinity Tags. Methods in Molecular Biology (Methods and Protocols). New York, NY: Humana Press. pp. 71–80. ISBN 978-1-4939-1034-2.

semanticscholar.org

api.semanticscholar.org

Mahajan R, Delphin C, Guan T, Gerace L, Melchior F (January 1997). "A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2". Cell. 88 (1): 97–107. doi:10.1016/S0092-8674(00)81862-0. PMID 9019411. S2CID 17819277.
Geiss-Friedlander R, Melchior F (December 2007). "Concepts in sumoylation: a decade on". Nature Reviews. Molecular Cell Biology. 8 (12): 947–956. doi:10.1038/nrm2293. PMID 18000527. S2CID 30462190.
Teng S, Luo H, Wang L (July 2012). "Predicting protein sumoylation sites from sequence features". Amino Acids. 43 (1): 447–455. doi:10.1007/s00726-011-1100-2. PMID 21986959. S2CID 14360760.
Ren J, Gao X, Jin C, Zhu M, Wang X, Shaw A, et al. (2009). "Systematic study of protein SUMOylation: Development of a site-specific predictor of SUMOsp 2.0". Proteomics. 9 (12): 3409–3412. doi:10.1002/pmic.200800646. PMID 19504496. S2CID 4900031.
Pichler A, Knipscheer P, Saitoh H, Sixma TK, Melchior F (October 2004). "The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type". Nature Structural & Molecular Biology. 11 (10): 984–991. doi:10.1038/nsmb834. PMID 15378033. S2CID 28085778.

worldcat.org

search.worldcat.org

Wimmer P, Schreiner S (September 2015). "Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways". Viruses. 7 (9): 4854–4872. doi:10.3390/v7092849. ISSN 1999-4915. PMC 4584293. PMID 26343706.
Seeler JS, Dejean A (March 2017). "SUMO and the robustness of cancer". Nature Reviews Cancer. 17 (3): 184–197. doi:10.1038/nrc.2016.143. ISSN 1474-1768. PMID 28134258.
Chang SC, Ding JL (2018-12-01). "Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870 (2): 165–175. doi:10.1016/j.bbcan.2018.08.002. ISSN 0304-419X. PMID 30318471.
Tam SY, Wu VW, Law HK (2020-04-08). "Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond". Frontiers in Oncology. 10: 486. doi:10.3389/fonc.2020.00486. ISSN 2234-943X. PMC 7156534. PMID 32322559.
Heo KS, Le NT, Cushman HJ, Giancursio CJ, Chang E, Woo CH, et al. (2015-03-02). "Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function". The Journal of Clinical Investigation. 125 (3): 1299–1310. doi:10.1172/JCI76453. ISSN 0021-9738. PMC 4362265. PMID 25689261.
Janaszak-Jasiecka A, Płoska A, Wierońska JM, Dobrucki LW, Kalinowski L (2023-03-09). "Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets". Cellular & Molecular Biology Letters. 28 (1): 21. doi:10.1186/s11658-023-00423-2. ISSN 1689-1392. PMC 9996905. PMID 36890458.
Zhang CP, Ding XX, Tian T, Li BJ, Wang CY, Jiang SS, et al. (2020-10-01). "Impaired lipophagy in endothelial cells with prolonged exposure to oxidized low‑density lipoprotein". Molecular Medicine Reports. 22 (4): 2665–2672. doi:10.3892/mmr.2020.11345. ISSN 1791-2997. PMC 7453646. PMID 32945384.
Wang X, Cao K, Sun X, Chen Y, Duan Z, Sun L, et al. (2015). "Macrophages in spinal cord injury: Phenotypic and functional change from exposure to myelin debris". Glia. 63 (4): 635–651. doi:10.1002/glia.22774. ISSN 1098-1136. PMC 4331228. PMID 25452166.
Du C, Chen X, Su Q, Lu W, Wang Q, Yuan H, et al. (January 2021). "The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications". International Journal of Molecular Sciences. 22 (19): 10618. doi:10.3390/ijms221910618. ISSN 1422-0067. PMC 8509021. PMID 34638970.